Health Care Digest: How federal shutdown hits one company, a JPM19 roundup — and more

A special edition of the Health Care Digest during the ongoing 37th annual J.P. Morgan Healthcare Conference going on in San Francisco. Aimmune Therapeutics Inc. CEO Jayson Dallas started his presentation Monday at the 37th annual J.P. Morgan Healthcare Conference describing the company as "a 2019 story." That may be more true than even Dallas knows. The Brisbane company (NASDAQ: AIMT) is on the cusp of a breakthrough in th e treatment of peanut allergy. It looks to win Food and Drug Administration…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news